Validity of standard gamble estimated quality of life in acute venous thrombosis.

[1]  S. Middeldorp,et al.  Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL. , 2013, Thrombosis research.

[2]  D. Coyle,et al.  Estimating quality of life in acute venous thrombosis. , 2013, JAMA internal medicine.

[3]  M. Pirmohamed,et al.  Comparative effectiveness of dabigatran, rivaroxaban, apixaban and warfarin in the management of patients with non-valvular atrial fibrillation , 2013, Clinical pharmacology and therapeutics.

[4]  Katherine Payne,et al.  A Systematic Review of Utility Values for Chemotherapy-Related Adverse Events , 2013, PharmacoEconomics.

[5]  S. Bermingham,et al.  Systematic review of the impact of urinary tract infections on health‐related quality of life , 2012, BJU international.

[6]  N. Sengupta,et al.  Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payer’s Perspective , 2012, PharmacoEconomics.

[7]  Anne K. Bothe,et al.  Assessment of respondent acceptability for preference measures in stuttering. , 2012, Journal of communication disorders.

[8]  H. Mcdonald,et al.  Cost-effectiveness of rivaroxaban in the prevention of venous thromboembolism: A Canadian analysis using the Ontario Ministry of Health Perspective , 2012, Journal of medical economics.

[9]  P. Adibi,et al.  Health-State Utilities in Liver Cirrhosis: A Cross-sectional Study , 2012, International journal of preventive medicine.

[10]  D. Revicki,et al.  Methods and issues associated with the use of quality-adjusted life-years , 2012, Expert review of pharmacoeconomics & outcomes research.

[11]  A. Morse,et al.  Determining Health-Related Quality of Life and Health State Utility Values of Urinary Incontinence in Women , 2011, Female pelvic medicine & reconstructive surgery.

[12]  H. Büller,et al.  Quality of life after pulmonary embolism: validation of the PEmb‐QoL Questionnaire , 2010, Journal of thrombosis and haemostasis : JTH.

[13]  A. Kaptein,et al.  Quality of life after pulmonary embolism: the development of the PEmb‐QoL questionnaire , 2009, Journal of thrombosis and haemostasis : JTH.

[14]  D. Lamping,et al.  VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis. , 2006, Journal of clinical epidemiology.

[15]  D. Lamping,et al.  Prospective Evaluation of Health-Related Quality of Life in Patients With Deep Venous Thrombosis , 2005 .

[16]  S. Cykert,et al.  Tamoxifen for Breast Cancer Prevention: A Framework for Clinical Decisions , 2004, Obstetrics and gynecology.

[17]  George Loewenstein,et al.  Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public , 2003, Quality of Life Research.

[18]  John Brazier,et al.  Use of visual analog scales in economic evaluation , 2003, Expert review of pharmacoeconomics & outcomes research.

[19]  S. Schroter,et al.  Evaluation of outcomes in chronic venous disorders of the leg: development of a scientifically rigorous, patient-reported measure of symptoms and quality of life. , 2003, Journal of vascular surgery.

[20]  K. Weiss,et al.  Preference assessment in patients with asthma , 2002, Expert review of pharmacoeconomics & outcomes research.

[21]  J. Brazier,et al.  The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.

[22]  D. Feeny,et al.  Do They Have a Role in the Measurement of Preferences for Health States , 2001 .

[23]  J. Brazier,et al.  Deriving a preference-based single index from the UK SF-36 Health Survey. , 1998, Journal of clinical epidemiology.

[24]  J E Ware,et al.  Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. , 1998, Journal of clinical epidemiology.

[25]  G. Torrance.  Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.

[26]  J. Neumann,et al.  Theory of games and economic behavior , 1945, 100 Years of Math Milestones.